Loading...
Loading...
Medical imaging (X-ray, CT, MRI), electronic health records, clinical trials, ECG/EEG, pathology
12,616 datasets
1605 patient records from the MIMIC-IV database were used to investigate the C-reactive protein-to-lymphocyte ratio (CLR) as a prognostic biomarker. The study by Supei Yin, last updated in May 2026, found higher CLR quartiles were significantly associated with increased 30-day and 365-day all-cause mortality. The dataset likely contains patient identifiers, CLR values, mortality outcomes, and covariates used for Cox regression and Kaplan-Meier analysis.
Supei Yin published a dataset on 2026-05-19 analyzing the C-reactive protein-to-lymphocyte ratio (CLR) as a prognostic marker. The data, sourced from the MIMIC-IV database, includes 1,605 patients diagnosed with both congestive heart failure and acute kidney injury. It was used to evaluate associations between CLR and 30-day and 365-day all-cause mortality.
Data from the MIMIC-IV database for 1,605 patients diagnosed with both congestive heart failure (CHF) and acute kidney injury (AKI). The dataset was used to investigate the prognostic value of the C-reactive protein-to-lymphocyte ratio (CLR) for 30-day and 365-day all-cause mortality. The data was uploaded by Supei Yin on May 19, 2026.
Data from the MIMIC-IV database was used to analyze 1,605 patients diagnosed with both congestive heart failure and acute kidney injury. The study, authored by Supei Yin and last updated in May 2026, investigates the association between the C-reactive protein-to-lymphocyte ratio (CLR) and 30-day and 365-day all-cause mortality.
Data from the MIMIC-IV database was used to analyze 1,605 patients diagnosed with both congestive heart failure and acute kidney injury. The study by Supei Yin, last updated in May 2026, investigates the prognostic value of the C-reactive protein-to-lymphocyte ratio for 30-day and 365-day all-cause mortality.
A 52-year-old female patient on pembrolizumab for vulvar squamous cell carcinoma developed bilateral optic neuritis. The case report, authored by Robert Finley and licensed under CC-BY-4.0, details management with plasmapheresis after non-response to intravenous steroids. It was last updated on May 20, 2026.
547 laboratory-confirmed COVID-19 patient records from Kilimanjaro Christian Medical Centre in Tanzania, spanning the first through fourth waves of the pandemic. The dataset contains 74 variables across demographic, clinical, laboratory, and outcome domains, with a mean patient age of 61.8 years and an in-hospital death rate of 34.6%. Gilbert Waria aggregated the data into a single Excel file, last updated in April 2026.
UK Biobank data from 349,995 participants tracked for a median of 18 years. The dataset, authored by Ruoyi Zhang and last updated in 2026, contains results from a prospective cohort study examining the association between metabolic syndrome and incident chronic pancreatitis.
Jiajing Dai published a dataset on figshare in 2026. The data likely contains measurements of VCAM1 expression in glioma stem cell-like cells and tumor microenvironment-associated astrocytes from mouse models, correlated with patient survival outcomes from clinical datasets. The file is 4.4 KB in size.
Data Sheet 2_Glia-derived VCAM1 promotes glioma progression.csv contains data from a study investigating VCAM1's role in glioma progression. The dataset likely includes expression correlations and survival outcomes from human glioma datasets and mouse models. The data was authored by Jiajing Dai and uploaded to figshare on April 24, 2026.
VCAM1 is highly enriched in glioma stem cell-like cells, with 86.5% of SOX2+, 86.3% of CD133+, and 93.4% of Ki67+ cells co-expressing it in the 73C model. This dataset likely contains tabular data from experiments correlating VCAM1 expression with patient survival and mouse model outcomes, authored by Jiajing Dai and published on figshare in 2026. Selective deletion of astrocytic VCAM1 extended median survival from 52 to 66.5 days in a hippocampal GL261 model.
Data Sheet 4_Glia-derived VCAM1 promotes glioma progression.csv contains research data on VCAM1 expression in glioma models and its correlation with patient survival. The dataset, authored by Jiajing Dai and released on figshare in April 2026, likely includes measurements from syngeneic and primary mouse glioma models and human clinical datasets. Its size is 61.5 KB.
86.5% of SOX2-positive glioma stem-like cells co-expressed VCAM1 in a mouse model. This dataset likely contains tabular data from experiments evaluating VCAM1 expression in human glioma datasets and mouse models, correlating it with survival outcomes. It was authored by Jiajing Dai and last updated on April 24, 2026.
A dataset supporting research on VCAM1's role in glioma progression. It includes data from human glioma datasets and mouse models correlating VCAM1 expression with survival outcomes. The dataset was authored by Jiajing Dai and last updated on April 24, 2026.
23 patients with small RAS-mutated thyroid nodules treated with microwave ablation, with data on nodule volume and adverse events collected between February 2022 and July 2024. The study, authored by Fengyun Cheng, reports a median volume reduction rate of 11.84% at 12 months and 100% at 24 months for a subset of patients.
An Inception-ResNetV2 model augmented with an SE attention mechanism achieved an ROC-AUC of 0.973 for detecting occult peritoneal metastasis in gastric cancer. The dataset, shared by Chao Zhang on figshare in 2026, likely contains tabular performance metrics for several convolutional neural network architectures evaluated on preoperative CT images. These findings suggest a potential approach for improving clinical predictive modeling by integrating advanced deep learning architectures with attention mechanisms.
A dataset analyzing demographic and recruitment setting risk factors for Plasmodium vivax, Plasmodium falciparum, and mixed malaria infections. It was authored by Cheikh Cambel Dieng and last updated on June 4, 2026. The data is stored in a 5.5 KB XLS file and includes statistical significance indicators for the presented distributions.
Ping-Yang Hong's retrospective cohort study analyzes 42 patients with pneumoconiosis and pneumothorax admitted to a tertiary hospital in China from January 2020 to July 2025. The dataset likely contains clinical characteristics, laboratory and imaging findings, management strategies, and in-hospital outcomes for these patients. Subgroup comparisons between first-time and recurrent pneumothorax cases are included.
A Spanish multicenter study analyzed 40 male patients with VEXAS syndrome, a rare autoinflammatory disorder caused by somatic UBA1 mutations. The retrospective study, conducted by the Grupo Español de Síndromes Mielodisplásicos (GESMD), details clinical features, 58 administered treatment lines, and prognostic associations. The dataset was last updated in April 2026.
Singapore's National University Hospital retrospectively evaluated eight children with bone-involved Langerhans cell histiocytosis treated with intravenous zoledronate between January 2020 and December 2025. The dataset records patient demographics, prior treatments, pain response, radiologic outcomes, and adverse effects. It was authored by Jann Adriel Sy and published on figshare in April 2026.